Filter
98
Filtered Results: 98
Text search:
Indian
Scientists’
Response
to
CoViD-19
Featured
Recommendations
8
New Publications
2
Language
Document type
Studies & Reports
60
Manuals
11
Guidelines
10
Strategic & Response Plan
8
Situation Updates
3
Fact sheets
2
No document type
2
App
1
Resource Platforms
1
Countries / Regions
Global
14
India
7
Latin America and the Carribbean
3
Kenya
2
Africa
2
South–East Asia Region
2
Thailand
1
China
1
Syria
1
Nigeria
1
Senegal
1
Malaysia
1
Mozambique
1
Tanzania
1
West and Central Africa
1
Middle East and North Africa
1
Eastern Europe and Central Asia
1
Western and Central Europe
1
Japan
1
East and Southern Africa
1
Argentina
1
Bangladesh
1
South Africa
1
Vietnam
1
Central African Republic
1
Ethiopia
1
South Sudan
1
Indonesia
1
Authors & Publishers
Publication Years
Category
COVID-19
10
Studies & Reports
9
Disaster Preparedness
4
Information, Education and Communication (IEC)
3
Non-communicable Diseases
3
Family Planning
2
Sanitation
2
x MEDBOX Issue Brief & Annual Reports x
2
Guidelines
2
WASH
2
Health Systems
2
Protection & Security
2
Pharmacy & Technology
1
Gender
1
Annual Report MEDBOX
1
IEC Material
1
Infection Control & Prevention (IPC)
1
Pediatrics
1
Health System Strengthening
1
NCD
1
Medical Devices & Equipment
1
Demograhic Health Surveys DHS
1
Policies
1
Women & Child Health
1
Humanitarian Crisis
1
Mental Health
1
Statistics
1
Immunization
1
General Guidelines
1
NTDs & Others
1
Laboratory Quality Assurance
1
Disease Prevention & Control
1
Global Health
1
Hygiene Promotion
1
Toolboxes
Global Impact: Socio-economic, health services, TB & HIV
12
Climate Change General
7
Country specific documents
6
Public Health
4
Reports
4
Climate & Health
3
Clinical Guidelines
3
Prevention & Preparedness
3
Fair Allocation & Ethical Aspects
3
Vaccine Hesitancy & Myths
3
Climate Change
3
Training
2
International
2
Infection Control General
2
Essential Medicines & Medical Devices
2
Hospital Readiness/Essential Health Services
2
RCCE Guides & Manuals
2
Planetary Health
2
Agriculture
2
Overview & reports
2
WASH Water Sanitation & Hygiene
2
Health Financing Toolbox
2
Prevention & Strategies
2
Poor Diet
2
Disaster Preparedness & Prevention
2
Natural Disaster
1
General Reports
1
Childhood TB
1
Laboratory Guidance
1
IPC
1
Surveillance
1
General Studies & Reports
1
Children
1
GO pre-deployment training
1
Sustainable Development Goals
1
Situation Reports & Updates
1
Studies
1
General
1
Context & Facts, Travel Advice
1
Information Material &Training
1
Public Health
1
Diagnostics & Laboratory Guidance
1
Surveillance & Contact tracing
1
For General Public & Community
1
Training, others
1
Protection of Vulnerable Groups
1
Child Protection
1
Country-specific Platforms
1
Physical Distancing
1
Oxygen Therapy
1
Blood Supply
1
Access & Strategy
1
Communication Material
1
Psychosocial Support
1
Logistics & Supply
1
TB/COVID-19
1
COVAX Initiative
1
Long COVID/ Post-COVID Syndrome
1
Handbooks & Manuals
1
Biodiversity shift
1
Rational use of Medicine
1
Guiding documents and principles
1
General documents One Health
1
Agriculture incl. animal husbandry
1
Disaster, Migration and Conflict
1
Pharmacovigilance
1
General
1
Ethics
1
Health Impact & Climate Change
1
Heat
1
Health Care In Conflict Settings
1
Strategies & Roadmaps
1
Studies & Reports
1
Overview, Studies & Reports
1
General Information
1
General Information & Methodology
1
Studies & Reports
1
Risk Factors
1
Assessment & Response
1
Education of students & professionals
1
International
1
Psychosocial Support
1
Other Resources
1
Community-based Mental Health Care
1
MHPSS Guidelines
1
WASH
1
Planetary Health
1
War, Conflict Areas & Refugees
1
Food & Nutrition
1
Capacity Building
1
Global Health Ethics
1
As COVID-19 has spread around the world, false and misleading information has spread with it.
A collection of 400 scientists have joined together to form Indian Scientists' Response to COVID-19 - committed to debunking false information about the virus.
The group have been communicating an...
Has the world worked together to tackle the coronavirus? July 2021. This research paper assesses how the global community has responded to calls for greater solidarity in tackling the COVID-19 pandemic, and presents the insights of key stakeholders and experts in global health governance, health sec...
WHY THIS GUIDE?
Because, in the face of crises and emergencies, it is vital to include a human rights perspective in responses. Vulnerable groups face major obstacles to accessing and benefiting from prevention, mitigation, and health care policies due to structural barriers of inequality. To offer...
This paper reviews the effects of vertical responses to COVID-19 on health systems, services, and people’s access to and use of them in LMICs, where historic and ongoing under-investments heighten vulnerability to a multiplicity of health threats. We use the term ‘vertical response’ to describ...
The authors state that researchers, governments and global agencies should proceed with particular care in the evaluation of candidate SARS-CoV-2 vaccines in LMICs, with effective communication to build trust and avoid generation of vaccine hesitancy. Vaccine efficacy is often highly variable betwee...
In the context of the coronavirus disease (COVID-19) pandemic response, WHO identifies young people as a priority target audience with specific concerns, experiences and behaviours. This policy brief provides relevant insights from behavioural evidence and a set of behavioural considerations for tho...
In the current absence of vaccine for COVID-19, public health response target breaking the chain of infection by focusing on the mode of transmission. This paper summarizes current evidence-base around the transmission dynamics, pathogenic, and clinical features of COVID-19, to critically identify i...
Learnings from the COVID-19 evidence response and recommendations for the future.
Reflections and recommendations from the evidence synthesis community.
PHARMA’S RESPONSE TO THE COVID-19 VACCINES CRISIS. Update Feb., 14, 2022. In September 2021, Amnesty International published A Double Dose of Inequality, which assessed the extent to which the pharmaceutical industry was restricting access to Covid-19 vaccines. This report updates that assessment ...
The two-year impact report for the Access to COVID-19 Tools (ACT) Accelerator details impact, case studies and timelines of key milestones for the Diagnostics, Therapeutics and Vaccines pillars, as well as the Health Systems and Response Connector.
In Control: A Practical Handbook for Professionals Working in Health Emergencies Internationally RKI
The greatest risk to persons engaging in international medical emergency response is poor preparation.
The In Control handbook hopes to provide a remedy.
At the time of writing, we are living through the Coronavirus (COVID-19) pandemic, a health emergency that disregards physical borders, brin...
The World Health Organization (WHO) and the global community of countries, partners, donors, technical experts, scientists and field implementation teams continue to work towards the ultimate goal of a world free of the burden of neglected tropical diseases (NTDs). This work is described in the NTD ...
The Lancet Countdown is an international collaboration that independently monitors the health consequences of a changing climate. Publishing updated, new, and improved indicators each year, the Lancet Countdown represents the
consensus of leading researchers from 43 academic institutions and UN ag...
13 May 2021
To avoid a reversal of progress from the adverse impacts of the COVID-19 pandemic, new knowledge and lessons from successful programmatic innovations are urgently needed to improve TB prevention and care. Experience can provide evidence for innovative approaches and strategies to mainta...
The WHO Living guideline: Drugs to prevent COVID-19 contains the Organization’s most up-to-date recommendations for the use of drugs to prevent COVID-19. The latest version of this living guideline is available in pdf format (via the ‘Download’ button) and via an online platform.
Guidelines ...
WHO Living guideline: Drugs to prevent COVID-19
recommended
Interim guidance 2 march 2021
Current use of drugs to prevent COVID-19 is variable, reflecting large-scale uncertainty. Numerous randomized trials of many different drugs are underway to inform practice. This first version of the Drugs to prevent COVID-19: A WHO living guideline contains new inform...
CEPI is seeking to raise $3.5 billion to implement CEPI’s next 5-year plan. To mitigate the immediate threat of COVID-19 variants, it is activating key elements of this plan now—and seeking to mobilise a portion of this $3.5 billion in 2021. We have already launched R&D programmes to initiate de...
Background paper 7
The Independent Panel for Pandemic Preparedness and Response
May 2021
